Affordable Access

Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study.

Authors
Type
Published Article
Journal
Clinical and experimental rheumatology
Publication Date
Volume
31
Issue
2 Suppl 76
Pages
96–102
Identifiers
PMID: 23101460
Source
Medline
License
Unknown

Abstract

Coexistence of ATA and ACA can be found at low prevalence in SSc. The clinical features of double-positive patients are not clearly dissimilar to those of patients harbouring only ATA. The data do not support a direct involvement of these antibodies in the pathogenesis of established SSc, but may lack statistical power.

Statistics

Seen <100 times